Trading looks for biotechs to decline – optionMONSTER Research (registration)
By Dr. Matthew Watson
 ETF Trends (blog) | Trading looks for biotechs to decline optionMONSTER Research (registration) Unusual option action is showing that someone is positioning for a pullback in the Nasdaq Biotechnology Index Fund. The IBB exchange-traded fund is off 0.17 ... ETFs and EarningsTheStreet.com (subscription) Nine ETFs To Buy NowForbes This Week in ETFs: April 9th EditionETF Database |
Uncategorized
Comments Off on Trading looks for biotechs to decline – optionMONSTER Research (registration) |
April 10th, 2010
This author published 5472 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research